Athletes’ Mesenchymal Stem Cells Could Be the Best Choice for Cell Therapy in Omicron-Infected Patients

New severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, Omicron, contains 32 mutations that have caused a high incidence of breakthrough infections or re-infections. These mutations have reduced vaccine protection against Omicron and other new emerging variants. This highlights the...

Descripción completa

Detalles Bibliográficos
Autores principales: Saheli, Mona, Khoramipour, Kayvan, Vosough, Massoud, Piryaei, Abbas, Rahmati, Masoud, Suzuki, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221912/
https://www.ncbi.nlm.nih.gov/pubmed/35741055
http://dx.doi.org/10.3390/cells11121926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221912/
https://www.ncbi.nlm.nih.gov/pubmed/35741055
http://dx.doi.org/10.3390/cells11121926

Ejemplares similares